Senior Director, US Medical Affairs, Obesity, Non-md

Pfizer Pfizer · Pharma · New York, NY

This role provides strategic and scientific leadership for US Medical Affairs activities supporting berobenatide in obesity and obesity-related comorbid conditions. It is accountable for shaping and executing the US medical strategy across the product lifecycle, with a strong emphasis on US medical affairs strategy, evidence generation, cross-functional coordination, and external scientific engagement.

What you'd actually do

  1. Lead strategic planning and execution of US Medical Affairs strategy for berobenatide in obesity and comorbid conditions.
  2. Translate strategy into integrated medical tactics and coordinate cross-functional execution.
  3. Ensures timely and appropriate management of the medical affairs budget and expenditure
  4. Support and shape the US evidence generation strategy including Phase IV, RWE, and publication activities.
  5. Ensures seamless and coordinated partnership with Field Medical leadership to achieve integration of insights into strategy development and execution

Skills

Required

  • Bachelor’s degree with 12+ years industry experience; Master’s with 10+ years; or PhD/PharmD with 7+ years.
  • Significant experience in Medical Affairs or closely related pharmaceutical functions.
  • Strong strategic thinking, leadership, and scientific communication skills.
  • Customer-oriented approach and ability to work in cross-functional teams
  • Proven strategic thinking skills and ability to interpret and implement strategic directions
  • Ability to manage multiple tasks and deal effectively with deadlines
  • Excellent verbal and written communication skills
  • Networking and negotiation skills
  • Strong Business acumen

Nice to have

  • Experience in obesity, metabolic, cardiometabolic, or related therapeutic areas preferred.
  • Knowledge of real-world evidence, health care economics and its impact on medical decision making desired
  • Creativity, resourcefulness, high energy and flexibility